CN Patent

CN102164909A — 用于治疗hcv的吡啶或吡嗪衍生物

Assigned to F Hoffmann La Roche AG · Expires 2011-08-24 · 15y expired

What this patent protects

本发明公开了其中R 1 、R 2a 、R 2b 、R 2c 、R 3 、Y和p如本文所定义且C2-C3是单键或双键的式I化合物，其为丙型肝炎病毒NS5b聚合酶抑制剂。本发明还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。

USPTO Abstract

本发明公开了其中R 1 、R 2a 、R 2b 、R 2c 、R 3 、Y和p如本文所定义且C2-C3是单键或双键的式I化合物，其为丙型肝炎病毒NS5b聚合酶抑制剂。本发明还公开了用于治疗HCV感染和抑制HCV复制的组合物和方法。

Drugs covered by this patent

Patent Metadata

Patent number: CN102164909A
Jurisdiction: CN
Classification: —
Expires: 2011-08-24
Drug substance claim: No
Drug product claim: No
Assignee: F Hoffmann La Roche AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.